Extreme neonatal hyperbilirubinemia and kernicterus spectrum disorder in Denmark during the years 2000-2015

J Perinatol. 2020 Feb;40(2):194-202. doi: 10.1038/s41372-019-0566-8. Epub 2020 Jan 6.

Abstract

Objective: To determine the incidence and etiology of extreme neonatal hyperbilirubinemia, defined as total serum bilirubin (TSB) ≥450 µmol/L, and kernicterus spectrum disorder (KSD) in Denmark between 2000 and 2015.

Study design: We identified all infants born between 01.01.2000 and 31.12.2015 with TSB ≥450 µmol/L, ratio of conjugated to TSB <0.30, gestational age ≥35 weeks, and postnatal age ≤4 weeks, using Danish hospitals' laboratory databases.

Result: We included 408 infants. The incidence of extreme neonatal hyperbilirubinemia among infants with gestational age ≥35 weeks was 42/100,000 during the study period with a seemingly decreasing incidence between 2005 and 2015. Twelve of the 408 infants developed KSD, (incidence 1.2/100,000) Blood type ABO isohemolytic disease was the most common explanatory etiology.

Conclusions: Our study stresses the importance of a systematic approach to neonatal jaundice and ongoing surveillance of extreme neonatal hyperbilirubinemia and KSD.

MeSH terms

  • Bilirubin / blood
  • Cohort Studies
  • Denmark / epidemiology
  • Exchange Transfusion, Whole Blood
  • Female
  • Gestational Age
  • Glucosephosphate Dehydrogenase Deficiency / epidemiology
  • Humans
  • Hyperbilirubinemia, Neonatal / complications
  • Hyperbilirubinemia, Neonatal / epidemiology*
  • Hyperbilirubinemia, Neonatal / therapy
  • Incidence
  • Infant, Newborn
  • Jaundice, Neonatal
  • Kernicterus / diagnosis
  • Kernicterus / epidemiology*
  • Kernicterus / etiology
  • Magnetic Resonance Imaging
  • Male
  • Phototherapy

Substances

  • Bilirubin